Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
9.54
+0.71 (8.04%)
At close: Jul 21, 2026, 4:00 PM EDT
8.81
-0.73 (-7.65%)
After-hours: Jul 21, 2026, 7:38 PM EDT
Niki BioSolutions Market Cap
Niki BioSolutions has a market cap or net worth of $7.77 million as of July 21, 2026. Its market cap has decreased by -32.45% in one year.
Market Cap
7.77M
Enterprise Value
7.56M
1-Year Change
-32.45%
Ranking
Category
Stock Price
$9.54
ChartMarket Cap Chart
Since December 18, 2018, Niki BioSolutions's market cap has decreased from $415.79M to $7.77M, a decrease of -98.13%. That is a compound annual growth rate of -40.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 7.77M | -10.00% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 6.17M |
| Pulmatrix | 6.14M |
| BioAtla | 6.12M |
| Purple Biotech | 6.11M |
| CollPlant Biotechnologies | 6.06M |
| Aptevo Therapeutics | 5.96M |
| Addex Therapeutics | 5.92M |
| Evogene | 5.91M |